 Home / Asthma / Pulmicort, budesonide |
 |
||||
Buy Pulmicort, budesonide  Buy Pulmicort to treat asthma. It comes in inhalant and Respule format, and is usually taken twice daily to treat and maintain chronic asthma. It is not indicated in the treatment of acute asthmatic attacks.Contraindications: Consult a doctor before taking Pulmicort if you are pregnant or breastfeeding, if you are allergic to any of its ingredients, if you are taking any other medications (especially ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, erythromycin, grapefruit juice, cimetidine, clarithromycin, rifampin, or mifepristone), or if you have or have a history of tuberculosis, liver disease, high blood pressure, diabetes, osteoporosis, stomach problems, eye problems, or allergies. To read more about Pulmicort, budesonide side effects, Pulmicort, budesonide dosage, and for more useful information about Pulmicort, budesonide, please click the product information link below.  PRODUCT INFORMATION
|
||||
|
||||
Other name(s): Budicort |
||||
Often prescribed for asthma |
||||
READ MORE ABOUT ASTHMA
Pulmicort, budesonideChemical Namesbudesonide Ingredients Active Ingredients: budesonide Non-Active Ingredients: Respules: disodium edetate, sodium chloride, sodium citrate, citric acid, polysorbate 80, and Water for Injection Indications Pulmicort is indicated in the maintenance treatment of asthma in patients six years of age and older. It is not indicated in the treatment of acute asthmatic attacks. How It Works Budesonide is a glucocorticoid steroid that, when inhaled, exerts an anti-inflammatory effect on the bronchial tubes, counteracting the inflammatory effects of asthma on the airways. Dosage Available inhaler/Rotahaler doses: 100 mcg, 200 mcg, 400 mcg Available Turbuhaler doses: 200 mcg Available Respule doses: 0.5mg 2ml, 1mg 2ml Inhaler/Rotahaler/Turbuhaler: Adult patients previously treated with bronchodilators alone should start by taking 200 to 400 mcg twice daily, then gradually increase as needed to a maximum of 400 mcg daily. Adult patients previously treated with inhaled corticosteroids should start by taking 200 to 400 mcg twice daily, then gradually increase as needed to a maximum of 800 mcg daily. Patients with mild to moderate asthma can feasibly be sufficiently treated by a single daily dose of 200 to 400 mcg. Adult patients previously treated with oral corticosteroids should start by taking 400 to 800 mcg twice daily, then gradually increase as needed to a maximum of 800 mcg daily. Pediatric patients previously treated with bronchodilators alone should start by taking 200 mcg twice daily, then gradually increase as needed to a maximum of 400 mcg daily. Pediatric patients previously treated with oral corticosteroids should start by taking 200 mcg twice daily, then gradually increase as needed to a maximum of 400 mcg daily. Patients with mild to moderate asthma can feasibly be sufficiently treated by a single daily dose of 200 to 400 mcg. Pediatric patients previously treated with bronchodilators alone should take no more than the maximum of 400 mcg daily. Respules: Patients previously treated with bronchodilators alone should start Respule treatment by taking 0.5 mg daily, either in a single dose or divided into two. Patients previously treated with inhaled corticosteroids should start Respule treatment by taking 0.5 mg daily, either in a single dose or divided into two. The highest recommended dose is a total of 1 mg daily. Patients previously treated with oral corticosteroids should start Respule treatment by taking 1 mg daily, either in a single dose or divided into two. The highest recommended dose is a total of 1 mg daily. In symptomatic children not responding to non-steroidal therapy, a starting dose of 0.25 mg once daily may be considered. If once-daily treatment does not provide adequate control, the total daily dose should be increased and/or administered as a divided dose. In all patients, it is desirable to downward-titrate to the lowest effective dose once asthma stability is achieved. Pulmicort Respules should be administered via jet nebulizer connected to an air compressor with an adequate air flow, equipped with a mouthpiece or suitable face mask. Ultrasonic nebulizers are not suitable for the adequate administration of Pulmicort Respules and, therefore, are not recommended. Precautions Consult a doctor before taking Pulmicort if you are pregnant or breastfeeding, if you are allergic to any of its ingredients, or if you have or have a history of tuberculosis, liver disease, high blood pressure, diabetes, osteoporosis, stomach problems, eye problems, or allergies. Avoid contact with people infected with chickenpox or measles while taking corticosteroids. Emotional stress, serious infection, injury or surgery may increase your body’s need for steroids. High doses of inhaled glucocorticoid steroids may decrease the formation and increase the breakdown of bone leading to weakened bones and ultimately osteoporosis and fractures. High doses may suppress the body's ability to make its own natural glucocorticoid in the adrenal gland. It is possible that these effects are shared by budesonide. People with suppression of their adrenal glands (which can be tested for by the doctor) need increased amounts of glucocorticoid steroids orally or intravenously during periods of high physical stress, for example, during infections, to prevent serious illness and shock. Particular care is needed for patients who are transferred from systemically active corticosteroids to Pulmicort because deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids. After withdrawal from systemic corticosteroids, a number of months are required for recovery of hypothalamic-pituitary-adrenal (HPA) function. Drug Interactions Consult a doctor before taking Pulmicort if you are taking ketoconazole. While inhaled budesonide is not known to have any interactions other than ketoconazole, inform your doctor if you are taking itraconazole, ritonavir, indinavir, saquinavir, erythromycin, grapefruit juice, cimetidine, clarithromycin, rifampin, or mifepristone. Adverse/Side Effects The most commonly noted side effects associated with inhaled budesonide are mild cough or wheezing; these effects may be minimized by using a bronchodilator inhaler, for example, albuterol (Ventolin), prior to the budesonide. A bad taste in the mouth, headache, nausea, diarrhea, thirst and tiredness have also been reported. If any of these effects continue or become bothersome, inform your doctor. Notify your doctor if you develop: rash, sore throat, mouth sores, swelling of the face, wheezing, breathing trouble, behavioral changes (especially in children), or vision changes. Oral candidiasis or thrush (a fungal infection of the throat) may occur in 1 in 25 persons who use budesonide without a spacer device on the inhaler. The risk is even higher with large doses but is less in children than in adults. Hoarseness or sore throat also may occur in 1 in 10 persons. Using a spacer device on the inhaler and washing one's mouth out with water following each use reduces the risk of both thrush and hoarseness. Less commonly, alterations in voice may occur. Overdose Pulmicort overdose is difficult to achieve and asymptomatic. If you suspect overdose, contact your local poison control center or emergency room immediately. Storage Instructions Store at room temperature, away from moisture and light, and out of reach of children and pets. |
